Skip to main content
Caplight Logo









apoQlar GmbH

apoQlar GmbH

Private
HamburgHealthcare & Life Scienceshttps://apoqlar.com/

Last Round

Series A

May 5, 2024

Total Funding Raised

$10.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

apoQlar GmbH is a medical software company that develops extended reality (XR) and mixed reality solutions for surgical planning, medical imaging, and clinical training.

Sector

Healthcare & Life Sciences

Verticals

AR/VR Experiences, Medical Imaging, Medical Devices, Data Visualization

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

mixed reality surgerysurgical planning softwaremedical XR3D holographic visualizationspatial AIcomputer vision segmentationdigital surgerymedical imaging softwareteleproctoringDICOM visualizationsurgical educationmedical device softwareXR healthcaresurgical navigationmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

apoQlar GmbH Comparables

Compare apoQlar GmbH with similar companies based on industry and business-model similarity.

apoQlar GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medivis
89%
Realize Medical
86%
Surgical Theater
83%

apoQlar GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 5, 2024
SeedJul 5, 2023

Key People

Founding team and executive leadership

Ulrich Neidel

CTO & CISO

Executive Team

apoQlar GmbH Investors

Notable investors and investment history

apoQlar GmbH investors
InvestorRounds
YZR CapitalSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 72, 8x the trailing average.

  • Dec 8, 2025

    Monthly visitors grew 2506% MoM, from 36 to 938.

apoQlar GmbH Filings

Explore SEC and related filing metadata, where available.

apoQlar GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about apoQlar GmbH's valuation, stock price, and market status.

Is apoQlar GmbH a public or private company?

apoQlar GmbH is a private company.

What is the current stock price of apoQlar GmbH?

apoQlar GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is apoQlar GmbH worth (valuation)?

Valuation information for apoQlar GmbH is not publicly available.

Can I buy apoQlar GmbH stock?

apoQlar GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was apoQlar GmbH's last funding round?

apoQlar GmbH's most recent funding round was Series A on May 5, 2024.

Who are the main investors in apoQlar GmbH?

Key investors in apoQlar GmbH include YZR Capital.

Will apoQlar GmbH IPO soon?

No public IPO plans have been announced for apoQlar GmbH.

How can I track apoQlar GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor apoQlar GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHamburg
Employee Range51
Year Founded2017
Last FundingMay 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?